For citations:
Aksenova T.A., Tsarenok S.Yu., Gorbunov V.V., Chaban N.Yu., Nechiporuk N.G., Erdyneeva S.D., Shcherbak V.A. The role of tixagevimab and cylgavimab combination in prevention of coronavirus infection in high-risk comorbid patients: results of 6-month study. Transbaikalian Medical Bulletin. 2023;(3):1-8. (In Russ.) https://doi.org/10.52485/19986173_2023_3_1
Email this article 